glp-1 receptor pathway GLP-1R Signaling and Functional Molecules in Incretin Therapy GLP-1R and Diabetes

GLP-1 RAs have emerged as promising agents in the treatment of OSA, primarily through their effects on weight reduction and metabolic modulation

Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, et al

Metabolic and hormone analysis: We measure hormones, blood sugar levels, and other markers that reveal how your body processes food and stores energy

Und einfach ausgedrckt: Es trgt dazu bei, dass du weniger Hunger versprst

Switching medications might be an option, but it's not always the first or best step

The ongoing CONFIDENCE trial (NCT05254002) is an international randomised controlled double-blind trial that will directly assess the effects of finerenone plus empagliflozin on albuminuria and characterise the efficacy and safety of this drug combination in the setting of type 2 diabetes